• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of bmjBMJ helping doctors make better decisionsSearch bmj.comLatest content
BMJ. Jun 27, 1992; 304(6843): 1644–1646.
PMCID: PMC1882380

Selective serotonin reuptake inhibitors.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (819K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Hall J. Fluoxetine: efficacy against placebo and by dose--an overview. Br J Psychiatry Suppl. 1988 Sep;(3):59–63. [PubMed]
  • Reimherr FW, Chouinard G, Cohn CK, Cole JO, Itil TM, LaPierre YD, Masco HL, Mendels J. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry. 1990 Dec;51 (Suppl B):18–27. [PubMed]
  • Burton SW. A review of fluvoxamine and its uses in depression. Int Clin Psychopharmacol. 1991 Dec;6 (Suppl 3):1–21. [PubMed]
  • Dunbar GC, Cohn JB, Fabre LF, Feighner JP, Fieve RR, Mendels J, Shrivastava RK. A comparison of paroxetine, imipramine and placebo in depressed out-patients. Br J Psychiatry. 1991 Sep;159:394–398. [PubMed]
  • Montgomery SA, Dufour H, Brion S, Gailledreau J, Laqueille X, Ferrey G, Moron P, Parant-Lucena N, Singer L, Danion JM, et al. The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry Suppl. 1988 Sep;(3):69–76. [PubMed]
  • Doogan DP, Caillard V. Sertraline in the prevention of depression. Br J Psychiatry. 1992 Feb;160:217–222. [PubMed]
  • Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffney M, Bick PA. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull. 1990;26(3):279–284. [PubMed]
  • Cottraux J, Mollard E, Bouvard M, Marks I, Sluys M, Nury AM, Douge R, Cialdella P. A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. Int Clin Psychopharmacol. 1990 Jan;5(1):17–30. [PubMed]
  • Mullin JM, Pandita-Gunawardena VR, Whitehead AM. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder. Br J Clin Pract. 1988 Feb;42(2):51–55. [PubMed]
  • Muijen M, Roy D, Silverstone T, Mehmet A, Christie M. A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients. Acta Psychiatr Scand. 1988 Sep;78(3):384–390. [PubMed]
  • Doogan DP. Toleration and safety of sertraline: experience worldwide. Int Clin Psychopharmacol. 1991 Dec;6 (Suppl 2):47–56. [PubMed]
  • Cooper GL. The safety of fluoxetine--an update. Br J Psychiatry Suppl. 1988 Sep;(3):77–86. [PubMed]
  • Dechant KL, Clissold SP. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs. 1991 Feb;41(2):225–253. [PubMed]
  • Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry. 1990 Feb;147(2):207–210. [PubMed]
  • Baldwin D, Fineberg N, Montgomery S. Fluoxetine, fluvoxamine and extrapyramidal tract disorders. Int Clin Psychopharmacol. 1991 Spring;6(1):51–58. [PubMed]
  • Meltzer HY, Young M, Metz J, Fang VS, Schyve PM, Arora RC. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J Neural Transm. 1979;45(2):165–175. [PubMed]
  • Halman M, Goldbloom DS. Fluoxetine and neuroleptic malignant syndrome. Biol Psychiatry. 1990 Sep 15;28(6):518–521. [PubMed]
  • Upward JW, Edwards JG, Goldie A, Waller DG. Comparative effects of fluoxetine and amitriptyline on cardiac function. Br J Clin Pharmacol. 1988 Oct;26(4):399–402. [PMC free article] [PubMed]
  • Edwards JG, Goldie A, Papayanni-Papasthatis S. Effect of paroxetine on the electrocardiogram. Psychopharmacology (Berl) 1989;97(1):96–98. [PubMed]
  • Guy S, Silke B. The electrocardiogram as a tool for therapeutic monitoring: a critical analysis. J Clin Psychiatry. 1990 Dec;51 (Suppl B):37–39. [PubMed]
  • Henry JA. Overdose and safety with fluvoxamine. Int Clin Psychopharmacol. 1991 Dec;6 (Suppl 3):41–47. [PubMed]
  • Miller LG, Bowman RC, Mann D, Tripathy A. A case of fluoxetine-induced serum sickness. Am J Psychiatry. 1989 Dec;146(12):1616–1617. [PubMed]
  • Wilcox JA. Abuse of fluoxetine by a patient with anorexia nervosa. Am J Psychiatry. 1987 Aug;144(8):1100–1100. [PubMed]
  • Szabadi E. Fluvoxamine withdrawal syndrome. Br J Psychiatry. 1992 Feb;160:283–284. [PubMed]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...